Skip to main content
OpenTrials
Completed

NCT Number: NCT01593969

A Trial of n-3 PUFA-Enriched Ready to Use Therapeutic Food for Childhood Severe Malnutrition

The investigators will perform a randomised controlled trial of the provision of food designed for rehabilitation of malnourished children that is supplemented with n-3 fatty acids compared to usual composition. The investigators want to see whether the provision of such a food normalises the deficiencies in essential fatty acids observed in severely malnourished children faster than standard composition.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–5 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Kilifi District Hospital

Kilifi, Coast, 80108, Kenya

About this study

Randomized controlled trial of n-3 Polyunsaturated Fatty Acid-Enriched Therapeutic Food for Severe Malnutrition.

Description of Study Design: Randomized Controlled Trial

Study Duration: 6 months (Trial); 12 months (All trial-related activities)

Description of Intervention: Provision of ready to use food (RUTF) enriched with flax seed oil, with or without fish oil, compared to conventional-composition RUTF. Interventional product will be given until nutritional recovery to a maximum of 12 weeks.

Design: Flax-enriched or standard RUTF allocation is randomised and double blind. Fish oil allocation is randomised within those receiving flax-enriched RUTF and is open label.

Location: Kilifi District, coastal Kenya.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children aged 6 months to 5 years old
  • Provision of informed consent
  • Severe malnutrition (one or more of mid-upper arm circumference <11.5cm, weight for height z score <-3, or nutritional oedema)
  • Stabilised and eligible to receive RUTF according to national guidelines

Exclusion criteria

  • Known HIV disease, tuberculosis or other chronic infection*
  • Known allergy or hypersensitivity to any of the product ingredients
  • Chronic infections such as HIV and tuberculosis and their treatments are likely to cause alterations in lipid metabolism that may confound interpretation of this pilot trial. national guidelines recommend offering provider-initiated testing for HIV for all severely malnourished children, and referral for comprehensive care in the case of a positive test.

Treatment and study plan

RUTF/Flax Oil

Dietary Supplement

Ready to Use Therapeutic Food

RUTF/Flax Oil plus additional Fish Oil

Dietary Supplement

Ready to Use Therapeutic Food

Standard RUTF

Dietary Supplement

Standard formulation RUTF given according to National Guidelines

Primary outcomes

  1. Total long chain PUFA in erythrocyte membranes at 3 months

    Time frame: 3 months

    Total long chain PUFA in erythrocyte membranes at 3 months

Secondary outcomes

  1. Ratio of n-6:n-3 PUFA in erythrocyte membranes at 3 months

    Time frame: 3 months

    Ratio of n-6:n-3 PUFA in erythrocyte membranes at 3 months

  2. Total long chain PUFA in CD3 cell membranes at 3 months

    Time frame: 3 months

    Total long chain PUFA in CD3 cell membranes at 3 months

  3. Ratio of n-6:n-3 PUFA in CD3 cell membranes at 3 months

    Time frame: 3 months

    Ratio of n-6:n-3 PUFA in CD3 cell membranes at 3 months

  4. Total long chain PUFA in plasma at 3 months

    Time frame: 3 months

    Total long chain PUFA in plasma at 3 months

  5. Ratio of n-6:n-3 PUFA in plasma at 3 months

    Time frame: 3 months

    Ratio of n-6:n-3 PUFA in plasma at 3 months

  6. Change in weight for height z score between baseline and 3 months

    Time frame: 3 months

    Change in weight for height z score between baseline and 3 months

  7. Change in mid upper arm circumference between baseline and 3 months

    Time frame: 3 months

    Change in mid upper arm circumference between baseline and 3 months

Sponsors and collaborators

Lead sponsor

University of Oxford

Other

Collaborators

  • KEMRI-Wellcome Trust Collaborative Research Program

Registry information

Official study title

A Randomised Controlled Trial of n-3 Polyunsaturated Fatty Acid-Enriched Therapeutic Food for Childhood Severe Malnutrition

Acronym: Njugu Plus

Important dates

Study start
2012
Primary completion
2013
Study completion
2014
First posted
May 8, 2012
Registry last updated
Aug 18, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.